Guideline | Guideline organisation/ society | First author, publication year |
---|---|---|
United States | ||
 American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care | ASCO | Meropol et al., 2009 [10] |
 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small Cell Lung Cancer | ASCO | Azzoli et al., 2009 [22] |
 American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer | ASCO/ASH | Rizzo et al., 2010 [23] |
 Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline | ASCO | Griggs et al., 2012 [24] |
 Screening, Assessment, and Care of Anxiety and Depressive Symptoms in Adults with Cancer: An American Society of Clinical Oncology Guideline Adaptation | ASCO | Andersen et al., 2014 [25] |
 Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline | ASCO | Rugo et al., 2016 [1] |
 Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline | ASCO | Gilligan et al., 2017 [26] |
 Anti-emetics: American Society of Clinical Oncology Clinical Practice Guideline Update | ASCO | Hesketh et al., 2017 [27] |
 Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology—Cancer Care Ontario Focused Guideline Update | ASCO/CCO | Van Poznak et al., 2017 [28] |
 Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update | ASCO/IDSA | Taplitz et al., 2018 [29] |
 Fertility Preservation in Patients with Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update | ASCO | Oktay et al., 2018 [30] |
 Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update | ASCO | Sohal et al., 2018 [31] |
 Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer: American Society of Clinical Oncology Clinical Practice Guideline | ASCO | Morris et al., 2018 [38] |
 Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update | ASCO/ SSO | Wong et al., 2018 [32] |
 Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: American Society of Clinical Oncology Guideline for Geriatric Oncology | ASCO | Mohile et al., 2018 [33] |
 Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update | ASCO | Forastiere et al., 2018 [34] |
Europe | ||
 Diagnosis and management of colorectal cancer | SIGN | Steele et al., 2011 [44] (revised 2016) |
 Management of lung cancer | SIGN | Fergusson et al., 2014 [46] |
 Management of adult testicular germ cell tumours | SIGN | Howard et al., 2011 [47] |
 Management of epithelial ovarian cancer | SIGN | Siddiqui et al., 2013 [45] |
 Cutaneous melanoma | SIGN | Brown et al., 2017 [39] |
Canada | ||
 A Pan-Canadian Clinical Practice Guideline: Assessment of Psychosocial Health Care Needs of the Adult Cancer Patient | CAPO | Howell et al., 2009 [35] |
 A Pan-Canadian Practice Guideline: Prevention, Screening, Assessment and Treatment of Sleep Disturbances in Adults with Cancer | CAPO | Howell et al., 2012 [36] |
 Pan-Canadian Practice Guideline: Screening, Assessment and Management of Psychosocial Distress, Depression and Anxiety in Adults with Cancer | CAPO | Howell et al., 2015 [37] |